OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer
Position
Chief Development Officer
Company
OSE Immunotherapeutics
NantesBiotechnologyHealth CareDescription
Dr Sonya Montgomery has been appointed as the Chief Development Officer of OSE Immunotherapeutics. Her extensive experience in leading R&D strategies at major life science companies will enhance the company’s development capabilities, overseeing key assets and strategic development of the product portfolio.
Quick answer
OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer (January 13, 2025). OSE Immunotherapeutics is based in Nantes, Pays De La Loire, France.
- Who is the new Chief Development Officer at OSE Immunotherapeutics?
- OSE Immunotherapeutics named Sonya Montgomery Chief Development Officer, announced January 13, 2025.
- What did OSE Immunotherapeutics announce on January 13, 2025?
- Dr Sonya Montgomery has been appointed as the Chief Development Officer of OSE Immunotherapeutics. Her extensive experience in leading R&D strategies at major life science companies will enhance the company’s development capabilities, overseeing key assets and strategic development of the product portfolio.
- What does OSE Immunotherapeutics do?
- OSE Immunotherapeutics SA is a biopharmaceutical company that announced a major expansion of its partnership with Boehringer Ingelheim.
- Where is OSE Immunotherapeutics based?
- OSE Immunotherapeutics is based in Nantes, Pays De La Loire, France.
- Which similar companies made leadership changes around the same time?
- MedQuest Associates (January 13, 2025), Gryphon Bio (January 13, 2025), The Bladder Cancer Advocacy Network (January 13, 2025) and QuantHealth (January 13, 2025) also announced leadership changes within 45 days of OSE Immunotherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- MedQuest Associates Appoints Warren Christopher ‘Chris’ Shea as Chief Legal Officer (January 13, 2025)
- Gryphon Bio Appoints Anthony DeLizza as Chief Business Officer (January 13, 2025)
- Meri-Margaret Deoudes Named Chief Executive Officer of The Bladder Cancer Advocacy Network (BCAN) (January 13, 2025)
- QuantHealth Appoints Sharon Dagan as Chief Architect and Siwar El Assad as Chief Information Security Officer (January 13, 2025)
- Pediatrix Appoints Mark S. Ordan as Chief Executive Officer (January 13, 2025)
- Outrun Therapeutics Appoints Matthew Fyfe as Chief Scientific Officer (January 13, 2025)
Who to call at OSE Immunotherapeutics, and when
A new leader at OSE Immunotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day OSE Immunotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OSE Immunotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OSE Immunotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OSE Immunotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OSE Immunotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.